We are live on ! Find out more
Bank of New York Mellon

Bank of New York Mellon Portfolio holdings

AUM $609B
1-Year Est. Return 40.19%
 

Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.

This Fund
S&P 500
This Quarter Est. Return
+8.51%
1 Year Est. Return
+40.19%
3 Year Est. Return
+118.86%
5 Year Est. Return
+156%
10 Year Est. Return
+606.23%
AUM
$517B
AUM Growth
+$27.6B
Cap. Flow
-$8.37B
Cap. Flow %
-1.62%
Top 10 Hldgs %
19.4%
Holding
4,590
New
277
Increased
1,772
Reduced
2,129
Closed
201

Top Sells

Rank Stock Value
1
FERG icon
Ferguson
FERG
+$692M
2
LIN icon
Linde
LIN
+$624M
3
MDT icon
Medtronic
MDT
+$527M
4
GS icon
Goldman Sachs
GS
+$340M
5
MSFT icon
Microsoft
MSFT
+$301M

Sector Composition

Rank Sector Weight
1 Technology 25.25%
2 Healthcare 13.3%
3 Financials 12.53%
4 Consumer Discretionary 10.81%
5 Communication Services 8.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
APPF icon
1526
AppFolio
APPF
$7.16B
$28.6M 0.01%
202,446
+1,432
+0.7% +$199K
EVER icon
1527
EverQuote
EVER
$858M
$28.5M 0.01%
873,135
+4,910
+0.6% +$164K
FATE icon
1528
Fate Therapeutics
FATE
$301M
$28.4M 0.01%
327,468
+23,128
+8% +$1.86M
VLUE icon
1529
iShares MSCI USA Value Factor ETF
VLUE
$9.76B
$28.4M 0.01%
270,489
+39,588
+17% +$4.18M
OI icon
1530
O-I Glass
OI
$1.05B
$28.4M 0.01%
1,736,486
-196,321
-10% -$3.33M
SNBR
1531
DELISTED
Sleep Number
SNBR
$28.3M 0.01%
257,683
-19,695
-7% -$2.24M
FUTU icon
1532
Futu Holdings
FUTU
$14.8B
$28.3M 0.01%
157,857
+115,764
+275% +$16.8M
TFSL icon
1533
TFS Financial
TFSL
$4.95B
$28.2M 0.01%
1,389,412
-1,815
-0.1% -$37.8K
BCE icon
1534
BCE
BCE
$21.9B
$28.2M 0.01%
571,355
+17,932
+3% +$869K
WLK icon
1535
Westlake Corp
WLK
$10.2B
$28.2M 0.01%
312,672
+58,015
+23% +$5.63M
PFGC icon
1536
Performance Food Group
PFGC
$16.8B
$28.1M 0.01%
580,297
-65,047
-10% -$3.44M
MEI icon
1537
Methode Electronics
MEI
$608M
$28.1M 0.01%
571,249
-23,219
-4% -$1.08M
ATH
1538
DELISTED
Athene Holding Ltd. Class A Common Shares
ATH
$28.1M 0.01%
416,451
-11,346
-3% -$682K
PSMT icon
1539
Pricesmart
PSMT
$5.51B
$28.1M 0.01%
308,697
+3,329
+1% +$297K
IOSP icon
1540
Innospec
IOSP
$2.31B
$28.1M 0.01%
309,962
+4,345
+1% +$431K
VYM icon
1541
Vanguard High Dividend Yield ETF
VYM
$83.9B
$28.1M 0.01%
267,966
+27,523
+11% +$2.89M
AAON icon
1542
Aaon
AAON
$7.23B
$28.1M 0.01%
672,374
-8,359
-1% -$368K
SHEN icon
1543
Shenandoah Telecom
SHEN
$737M
$28M 0.01%
577,106
+10,329
+2% +$512K
DASH icon
1544
DoorDash
DASH
$94.3B
$28M 0.01%
156,966
+131,928
+527% +$19.3M
AROC icon
1545
Archrock
AROC
$6.06B
$27.7M 0.01%
3,111,986
-162,985
-5% -$1.52M
BEAM icon
1546
Beam Therapeutics
BEAM
$2.75B
$27.7M 0.01%
215,175
+43,707
+25% +$3.48M
MDRX
1547
DELISTED
Veradigm Inc. Common Stock
MDRX
$27.7M 0.01%
1,496,022
-95,566
-6% -$1.61M
PRFT
1548
DELISTED
Perficient Inc
PRFT
$27.7M 0.01%
343,984
-15,867
-4% -$1.12M
BBIO icon
1549
BridgeBio Pharma
BBIO
$15.6B
$27.6M 0.01%
453,096
+84,707
+23% +$4.84M
CSGS
1550
DELISTED
CSG Systems International
CSGS
$27.6M 0.01%
584,025
-18,348
-3% -$836K

Similar funds

Bank of New York Mellon's Q2 2021 Portfolio in Review

As of Q2 2021, Bank of New York Mellon held 4,590 positions worth $517B, up 5.6% from $489B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Bank of New York Mellon's Q2 2021 filing shows 277 new, 1,772 increased, 2,129 reduced and 201 closed positions. Its largest new stake was Organon & Co: 4,240,135 shares worth $128M. The largest sale was Ferguson, an estimated $692M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.

  • Bank of New York Mellon's largest Q2 2021 buy was Organon & Co: 4,240,135 shares worth $128M.
  • Bank of New York Mellon added most to Vanguard FTSE Developed Markets ETF in Q2 2021, an estimated $307M increase.
  • Bank of New York Mellon's biggest Q2 2021 reduction was Ferguson, cutting an estimated $692M.
  • Bank of New York Mellon fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $164M.
  • Bank of New York Mellon's ten largest holdings make up 19% of its $517B portfolio in Q2 2021.
  • Bank of New York Mellon opened 277 new positions and closed 201 in Q2 2021.
  • Bank of New York Mellon's portfolio value rose 5.6% quarter-over-quarter to $517B.

Based on Bank of New York Mellon's 13F filing for Q2 2021, filed 11 Aug 2021.